These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10411168)

  • 1. The role of mycophenolate mofetil in the management of pemphigus.
    Nousari HC; Anhalt GJ
    Arch Dermatol; 1999 Jul; 135(7):853-4. PubMed ID: 10411168
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil monotherapy for pemphigus vulgaris.
    Bredlich RO; Grundmann-Kollmann M; Behrens S; Kerscher M; Peter RU
    Br J Dermatol; 1999 Nov; 141(5):934. PubMed ID: 10583186
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
    Grundmann-Kollmann M; Kaskel P; Leiter U; Krähn G; Behrens S; Peter RU; Kerscher M
    Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pemphigus vulgaris with mycophenolate mofetil.
    Enk AH; Knop J
    Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial and the treatment of pemphigus vulgaris.
    Margolis DJ
    J Invest Dermatol; 2010 Aug; 130(8):1964-6. PubMed ID: 20631749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY; Tsai K; Aoki V; Santi CG; Maruta CW; Rivitti E
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH; Marks JG; Helm KF
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case with Listeria meningitis during administration of mycophenolate mofetil for pemphigus vulgaris.
    Akyol M; Ozçelik S; Engin A; Ozel l ahin G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1447-8. PubMed ID: 17958877
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil.
    Howell SM; Bessinger GT; Altman CE; Belnap CM
    J Am Acad Dermatol; 2005 Sep; 53(3):541-3. PubMed ID: 16112379
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
    Baskan EB; Yilmaz M; Tunali S; Saricaoglu H
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S; Platamone A; Alaimo R; Bongiorno MR
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
    Williams JV; Marks JG; Billingsley EM
    Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.
    Balestri R; Rech G; Girardelli CR
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e435-e436. PubMed ID: 32359182
    [No Abstract]   [Full Text] [Related]  

  • 18. Is mycophenolic acid effective for the treatment of pemphigus?
    Bystryn JC
    Arch Dermatol; 1999 Jul; 135(7):854-5. PubMed ID: 10411169
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence-based pemphigus treatment?
    Stirling L; Kirsner RS
    J Invest Dermatol; 2010 Aug; 130(8):1963. PubMed ID: 20631748
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH; Knop J
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.